Immune globulin subcutaneous, human – klhw 20% solution...

Journal of Allergy and Clinical Immunology 2020 / 02 Vol. 145; Iss. 2

Immune globulin subcutaneous, human – klhw 20% solution (Xembify®, IGSC-C 20%) is effective in primary humoral immunodeficiency (PI): results from a prospective, open-label, multicenter, phase 3 study

Sleasman, John, Lumry, William, Hussain, Iftikhar, Wedner, H. James, Harris, James, Mondou, Elsa, Lin, Jiang, Hames, Carrie, Querolt, Montse, Stein, Mark
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
145
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2019.12.648
Date:
February, 2020
File:
PDF, 103 KB
2020
Conversion to is in progress
Conversion to is failed